Coherus Oncology CHRS
NASDAQ CHRS
$0.75 +0.00 (+0.36%)
As of: Nov 6, 2026 · 10:06 AM EST

Coherus Oncology (CHRS) EV to CFO (2019 - 2025)

Updated

Coherus Oncology's (CHRS) EV to CFO stood at 22.95 in Q1 2025.

Analysis

Coherus Oncology (CHRS) EV to CFO (2019 - 2025) Analysis & Trends

On a TTM basis, Coherus Oncology's EV to CFO came in at -742.89 as of Mar 31, 2025; for FY2020, it came in at 4.67, down 87.9% from FY2019.

  • Across earlier years, EV to CFO came in at 38.40 in FY2019.
  • The Q1 2025 figure is the highest quarterly EV to CFO since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,221.28 Bn 1,194.89 Bn 20.46 Bn
2 Johnson & Johnson 653.62 Bn 573.48 Bn 17.30 Bn
3 AbbVie 509.01 Bn 477.02 Bn 13.12 Bn
4 Merck 362.31 Bn 325.26 Bn 13.19 Bn
5 Novartis Ag 312.49 Bn 285.73 Bn -
6 Astrazeneca 285.84 Bn 259.73 Bn 13.26 Bn
7 Amgen 248.19 Bn 199.85 Bn 7.58 Bn
8 Gilead Sciences 208.17 Bn 183.27 Bn 6.73 Bn
9 Pfizer 166.64 Bn 114.00 Bn 12.56 Bn
10 Coherus Oncology 116.82 Mn -519.32 Mn 10.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 22.95
Sep 30, 2021 15.87
Jun 30, 2021 7.39
Mar 31, 2021 4.71
Dec 31, 2020 4.67
Sep 30, 2020 5.90
Jun 30, 2020 5.60
Mar 31, 2020 9.68
Dec 31, 2019 38.40
API Access

Coherus Oncology EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CHRS&period=max&api_key=YOUR_API_KEY